Annovis Bio, Inc. (ANVS)
NYSE·Healthcare·Biotechnology
$0.84
—
Mkt Cap $36.06M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
Implied Upside
+2938.2%
Consensus $25.67 vs current $0.84
NYSE·Healthcare·Biotechnology
$0.84
—
Mkt Cap $36.06M
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
+2938.2%
Consensus $25.67 vs current $0.84